Biofrontera Inc. Common Stock (BFRI)
Biofrontera Inc. is a biopharmaceutical company focused on developing and commercializing innovative products for dermatological conditions. It primarily markets its leading prescription product, Ameluz, for actinic keratosis, and develops treatments leveraging its proprietary photodynamic therapy technology. The company aims to address unmet medical needs in dermatology through research, development, and commercialization efforts.
Company News
Biofrontera reported a 15% revenue increase in Q2 2025, with record Ameluz sales and strategic shifts towards a royalty model. The company is advancing clinical trials for label expansions in actinic keratosis and basal cell carcinoma treatments.
Biofrontera reported Q2 2025 revenues of $9.0 million, a 15% increase from the previous year. The company restructured its relationship with Biofrontera AG, acquiring US intellectual property and securing $11 million in funding. Despite increased legal expenses, the company saw improvements in sales effectiveness and is progressing with clinical trials for Ameluz®.
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 54.55% and 88.87%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Shares of Jabil Inc. (NYSE: JBL) fell sharply during Friday’s session after the company reported financial second-quarter results and issued FY25 guidance below estimates. Jabil posted adjusted earnings of $1.68 per share, beating estimates of $1.66 per share. The company’s quarterly sales came in at $6.77 billion, missing expectations of $6.89 billion. Jabil shares dipped 14.2% to $126.56 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 189% to $0.4047. VERB's MARKET.live launched Facebook and Instagram social shopping technology integration. Better Therapeutics, Inc. (NASDAQ: BTTX) surged 108% to $0.0728. Better Therapeutics recently said it will seek strategic alternatives and will be delisted from the Nasdaq. Jet.AI Inc. (NASDAQ: JTAI) shares climbed 76.7% to $1.1950. Cardlytics, Inc. (NASDAQ: CDLX) rose 57.1% to $12.86 after the company reported better-than-expected fourth-quarter earnings. American Vanguard Corporation (NYSE: AVD) climbed 25.8% to $13.32 following fourth-quarter financial results. Blend Labs, Inc. (NASDAQ: BLND) climbed 24.3% to $2.92 after the company reported fourth-quarter financial results. HCM Acquisition Corp (NASDAQ: HCMA) gained 22.8% to $12.00. Solidion Technology Inc. (NASDAQ: STI) rose 22.2% to $1.5897. The company announced the pricing of a $3.85 million private placement. Tredegar Corporation (NYSE: TG) surged 18% to $4.73 following fourth-quarter financial results. BranchOut Food Inc. (NASDAQ: BOF) rose 17.3% to $2.20. BranchOut Food will debut new products at Natural Products Expo West. Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) rose 16.3% to $283.29 after the company announced FDA approval of Rezdiffra for the treatment of patients with noncirrhotic NASH with moderate to advanced liver fibrosis. Secoo Holding Limited (NASDAQ: SECO) gained 16% to $0.5017. Direct Digital Holdings, Inc. (NASDAQ: DRCT) jumped 15.1% to $31.81. Roth MKM recently maintained a Buy rating on the stock and raised its price target from $12.50 ...
Penny stocks to watch with relative strength in the stock market today. The post Best Penny Stocks To Watch After Powell’s Jackson Hole Speech appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.